Effects of Naproxen on Physical Performance
NCT00410995 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2007-10-11
Summary
The purpose of this study is to determine the effect of daily use of Naproxen (a commonly used over-the-counter NSAID) on the physical performance of athletes, as measured by maximum oxygen consumption.
Conditions
- Healthy
Interventions
- DRUG
-
Naproxen
Sponsors & Collaborators
-
University of Oklahoma
lead OTHER
Principal Investigators
-
LaMont Cavanagh, MD · University of Oklahoma-Tulsa
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 30 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2004-05-31
- Completion
- 2006-08-31
Countries
- United States
Study Locations
More Related Trials
-
Changes in mRNA Expression Following Exposure to Naproxen
NCT01090596 ·Status: COMPLETED ·Phase: NA
-
A Clinical Trial to Compare Safety and Effectiveness for Relieving Tenderness of 10% Naproxen Gel vs. a 2.32% Diclofenac Diethylamine Gel in the Treatment of Strains and Bruises of the Legs.
NCT05026320 ·Status: COMPLETED ·Phase: PHASE2
-
Naproxen Sodium (2 x 220 mg) Fasted Comparative Bioavailability Study
NCT03167541 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics Study Comparing Naproxen Sodium Extended Release and Naprelan
NCT00969449 ·Status: COMPLETED ·Phase: PHASE1
-
Study Evaluating the Bioavailability of Naproxen 375 mg in Two Formulations
NCT00692055 ·Status: COMPLETED ·Phase: PHASE1
-
Bioequivalence Study of Naproxen Sodium 220 mg & Pseudoephedrine HCl 120 mg ER Tablets of Dr. Reddy's Under Fasting Conditions
NCT01131728 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics Study: Determination of Naproxcinod and Its Metabolites After Oral Administration in Male
NCT01404598 ·Status: COMPLETED ·Phase: PHASE1
-
A Pharmacokinetic Trial of Naproxen Sodium and Diphenhydramine Hydrochloride Soft Capsules Versus Naproxen Sodium and Diphenhydramine Hydrochloride Tablets in Healthy Adult Subjects
NCT03396250 ·Status: COMPLETED ·Phase: PHASE1
-
Anti-inflammatory Agents and Cholesterol Metabolism
NCT01279395 ·Status: TERMINATED
-
Self Selection Trial of Naproxen Sodium
NCT01383486 ·Status: COMPLETED ·Phase: PHASE3
-
Effectiveness of Theramine on Chronic Back Pain
NCT01468025 ·Status: COMPLETED ·Phase: PHASE3
-
Non-steroidal Anti-inflammatory Affect on Kidneys in Endurance Distances
NCT02272725 ·Status: COMPLETED ·Phase: PHASE3
-
Pharmacokinetics Study of XG005 Capsule
NCT04499209 ·Status: COMPLETED ·Phase: PHASE1
-
The Effects of NSAIDs on Bone Metabolism Following Exercise
NCT05512013 ·Status: COMPLETED ·Phase: PHASE1
-
A Pharmacokinetics and Safety Study of Naproxcinod in Subjects With Impaired Renal Function
NCT00674856 ·Status: COMPLETED ·Phase: PHASE1
-
Relative Bioavailability Study of Naproxen Delayed-Release Tablets (375 mg)
NCT00959439 ·Status: COMPLETED ·Phase: PHASE1
-
A Pharmacokinetic Trial of Naproxen Sodium and Diphenhydramine Hydrochloride Soft Capsules Versus Naproxen Sodium and Diphenhydramine Hydrochloride Tablets in Healthy Adult Subjects Under Fed Conditions
NCT03424135 ·Status: COMPLETED ·Phase: PHASE1
-
Fast & Fed Pharmacokinetic (PK) Study
NCT00692016 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess Bioquivalence Between a Novel Naproxen Sodium 275 mg Film-coated Tablet and Nalgesin Naproxen Sodium 275 mg Film-coated Tablet in Healthy Adult Volunteers
NCT03697889 ·Status: COMPLETED ·Phase: PHASE1
-
Pilot Study of OXP005 to Assess Gastroduodenal Irritation
NCT02408978 ·Status: COMPLETED ·Phase: PHASE1
-
NSAID Use for Treating Dysmenorrhea and Preventing Chronic Pelvic Pain (NSAID HEAL)
NCT06861920 ·Status: RECRUITING ·Phase: PHASE4
-
Bioequivalence Study of Naproxen Sodium 550 mg Tablets Under Fasting Condition
NCT01052129 ·Status: COMPLETED ·Phase: PHASE1
-
Naproxen Sodium ER Pharmacokinetic Study
NCT00818415 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of Dual Cyclooxygenase-2 and Carbonic Anhydrase Inhibition
NCT00780325 ·Status: TERMINATED ·Phase: PHASE1
-
Variability in Response to Non-steroidal Anti-inflammatory Drugs
NCT02502006 ·Status: TERMINATED ·Phase: PHASE1